医薬品研究製造業務受託(CRAM)の世界市場2019-2023

◆英語タイトル:Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023
◆商品コード:IRTNTR31081
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年3月27日
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、医薬品研究製造業務受託(CRAM)の世界市場について調査・分析し、市場概要、市場環境、医薬品研究製造業務受託(CRAM)市場規模、サービス別(CMO、CRO)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・医薬品研究製造業務受託(CRAM)の世界市場概要
・医薬品研究製造業務受託(CRAM)の世界市場環境
・医薬品研究製造業務受託(CRAM)の世界市場動向
・医薬品研究製造業務受託(CRAM)の世界市場規模
・医薬品研究製造業務受託(CRAM)の世界市場:業界構造分析
・医薬品研究製造業務受託(CRAM)の世界市場:サービス別(CMO、CRO)
・医薬品研究製造業務受託(CRAM)の世界市場:地域別市場規模・分析
・医薬品研究製造業務受託(CRAM)の北米市場規模・予測
・医薬品研究製造業務受託(CRAM)のヨーロッパ・中東・アフリカ市場規模・予測
・医薬品研究製造業務受託(CRAM)のアジア太平洋市場規模・予測
・医薬品研究製造業務受託(CRAM)の主要国分析
・医薬品研究製造業務受託(CRAM)の世界市場:成長要因、課題
・医薬品研究製造業務受託(CRAM)の世界市場:競争環境
・医薬品研究製造業務受託(CRAM)の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The significant advances in their healthcare infrastructure and technological advances in their drug development processes. As a result, large and medium-sized pharmaceutical companies from developed countries are outsourcing the research and manufacturing operations of various drugs and therapies to the vendors in such countries. Factors such as the increasing number of US FDA-approved manufacturing plants in such countries also encourage outsourcing. The rapidly evolving market environment and the strong support of the Government of China help the country specialize in the research of drugs, including regenerative medicines and small-molecule based drugs. Therefore, the global pharmaceutical CRAM market is expected to grow strongly during the forecast period. Technavio’s analysts have predicted that the pharmaceutical contract research and manufacturing (CRAM) market will register a CAGR of more than 9% by 2023.
Market Overview
Growing need to focus on core competencies
One of the growing changes in the global pharmaceutical market is the increasing volume of outsourcing of partial or complete research and manufacturing processes to CROs and CMOs. This is primarily due to the rising focus of the sourcing companies on developing therapies for large indications such as oncology, neurology, and autoimmune disorders.
Stereotypical nature of CMOs
Despite the growing popularity of CMOs in emerging countries such as China and India, the global pharmaceutical CRAM market faces a major challenge from the limited offerings of the CMOs. This is currently a major challenge faced by CMOs, which is expected to significantly hinder the growth of the global pharmaceutical CRAM market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the pharmaceutical contract research and manufacturing (CRAM) market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY SERVICE
• Market segmentation by service
• Comparison by service
• CMO – Market size and forecast 2018-2023
• CRO – Market size and forecast 2018-2023
• Market opportunity by service
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Catalent, Inc
• IQVIA
• Lonza
• Thermo Fisher Scientific Inc.
PART 13: APPENDIX
• Research methodology
• List of abbreviations


Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Service – Market share 2018-2023 (%)
Exhibit 18: Comparison by service
Exhibit 19: CMO – Market size and forecast 2018-2023 ($ billions)
Exhibit 20: CMO – Year-over-year growth 2019-2023 (%)
Exhibit 21: CRO – Market size and forecast 2018-2023 ($ billions)
Exhibit 22: CRO – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by service
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America – Market size and forecast 2018-2023 ($ billions)
Exhibit 28: North America – Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Asia – Market size and forecast 2018-2023 ($ billions)
Exhibit 31: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Asia
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ billions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ billions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Boehringer Ingelheim International GmbH – Vendor overview
Exhibit 48: Boehringer Ingelheim International GmbH – Business segments
Exhibit 49: Boehringer Ingelheim International GmbH – Organizational developments
Exhibit 50: Boehringer Ingelheim International GmbH – Geographic focus
Exhibit 51: Boehringer Ingelheim International GmbH – Segment focus
Exhibit 52: Boehringer Ingelheim International GmbH – Key offerings
Exhibit 53: Boehringer Ingelheim International GmbH – Key customers
Exhibit 54: Catalent, Inc – Vendor overview
Exhibit 55: Catalent, Inc – Business segments
Exhibit 56: Catalent, Inc – Organizational developments
Exhibit 57: Catalent, Inc – Geographic focus
Exhibit 58: Catalent, Inc – Segment focus
Exhibit 59: Catalent, Inc – Key offerings
Exhibit 60: Catalent, Inc – Key customers
Exhibit 61: IQVIA – Vendor overview
Exhibit 62: IQVIA – Business segments
Exhibit 63: IQVIA – Organizational developments
Exhibit 64: IQVIA – Geographic focus
Exhibit 65: IQVIA – Segment focus
Exhibit 66: IQVIA – Key offerings
Exhibit 67: IQVIA – Key customers
Exhibit 68: Lonza – Vendor overview
Exhibit 69: Lonza – Business segments
Exhibit 70: Lonza – Organizational developments
Exhibit 71: Lonza – Geographic focus
Exhibit 72: Lonza – Segment focus
Exhibit 73: Lonza – Key offerings
Exhibit 74: Lonza – Key customers
Exhibit 75: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 76: Thermo Fisher Scientific Inc. – Business segments
Exhibit 77: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 78: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 79: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 80: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 81: Thermo Fisher Scientific Inc. – Key customers
Exhibit 82: Validation techniques employed for market sizing



【掲載企業】

Boehringer Ingelheim International GmbH, Catalent, Inc, IQVIA, Lonza, Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医薬品研究製造業務受託(CRAM)の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆